Clinical Outcome of Treatment of Ulcerative Colitis in Adult
NCT06143163 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2023-11-22
Summary
1. characterize the response to current medical therapy in adult with ulcerative colitis .
2. Detect prognostic factors of response of biological therapy in adult with ulcerative colitis
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-29
- Primary Completion
- 2025-12-29
- Completion
- 2026-01-29
More Related Trials
-
Biological Therapy in Patients With Inflammatory Bowel Disease
NCT05599867 ·Status: UNKNOWN
-
Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis
NCT02569333 ·Status: COMPLETED ·Phase: NA
-
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
NCT02738125 ·Status: COMPLETED
-
Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis
NCT01301976 ·Status: COMPLETED
-
Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparing the Accuracy of Different Ultrasound-based Scores to Assess Disease Severity in Patients with Inflammatory Bowel Disease
NCT06705972 ·Status: NOT_YET_RECRUITING
-
Bowel Urgency in Inflammatory Bowel Disease
NCT06069167 ·Status: COMPLETED
-
Oncostatin M in Ulcerative Colitis Patients
NCT05974332 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis
NCT05735665 ·Status: UNKNOWN ·Phase: NA
-
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
NCT02229344 ·Status: COMPLETED
-
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788 ·Status: UNKNOWN
-
Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences
NCT05737836 ·Status: NOT_YET_RECRUITING
-
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
NCT02435160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Value Of ACE Index (Albumin, CRP And Endoscopy) In Predicting Intra Venous Steroid Response In Acute Severe Ulcerative Colitis In Assiut University Hospitals
NCT06267651 ·Status: NOT_YET_RECRUITING
-
Effect of Standardized Nutritional Therapy on Clinical Prognosis and Cost-effectiveness of Inflammatory Bowel Disease
NCT04349943 ·Status: UNKNOWN ·Phase: NA
-
Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
NCT06721767 ·Status: RECRUITING
-
Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients
NCT05720221 ·Status: COMPLETED
-
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
NCT05002166 ·Status: RECRUITING
-
Open-Label Adalimumab for Ulcerative Colitis Patients
NCT00421642 ·Status: COMPLETED ·Phase: PHASE1
-
Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis
NCT02922374 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
NCT01852760 ·Status: COMPLETED
-
Care Path for the Management of Ulcerative Colitis
NCT01882426 ·Status: TERMINATED ·Phase: PHASE4
-
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03016780 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
NCT05341401 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3